TSVT NASDAQ
2seventy bio, Inc.
1W: +0.0%
1M: +0.8%
3M: +104.1%
1Y: +11.6%
3Y: -64.3%
$5.00
Last traded 2025-05-12 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$38M
-62.3% ▼
5Y CAGR: -3.1%
Gross Profit
$15M
-81.7% ▼
5Y CAGR: -18.0%
Operating Income
-$115M
+51.4% ▲
Net Income
-$57M
+73.7% ▲
EPS (Diluted)
$-1.10
+75.1% ▲
EBITDA
-$98M
+52.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $248M | $55M | $91M | $100M | $38M |
| YoY Growth | +460.1% | -78.0% | +67.8% | +9.7% | -62.3% |
| Cost of Revenue | $5M | $13M | $26M | $17M | $23M |
| Gross Profit | $243M | $42M | $65M | $83M | $15M |
| Gross Margin | 97.8% | 76.9% | 71.3% | 83.1% | 40.4% |
| R&D Expenses | $296M | $262M | $249M | $231M | $77M |
| SG&A Expenses | $91M | $94M | $79M | $69M | $44M |
| Operating Expenses | $387M | $355M | $328M | $321M | $131M |
| Operating Income | -$145M | -$314M | -$263M | -$238M | -$115M |
| Operating Margin | -58.3% | -575.0% | -287.3% | -236.7% | -304.9% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$120M | -$292M | -$254M | -$218M | -$57M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$138M | -$276M | -$254M | -$218M | -$57M |
| Net Margin | -55.7% | -506.6% | -277.8% | -216.7% | -151.2% |
| EPS (Diluted) | $-5.93 | $-11.71 | $-7.13 | $-4.42 | $-1.10 |
| EBITDA | -$131M | -$297M | -$251M | -$206M | -$98M |
| Shares Outstanding | 23M | 24M | 36M | 49M | 52M |